Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749–61. https://doi.org/10.1016/s0140-6736(14)60121-5.
World Health Organization. Global health estimates 2019: deaths by cause, age, sex, by country and by region, 2000–2019. Geneva: World Health Organization; 2020. Available from: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death.
Nishikawa H, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Sarcopenia and frailty in liver cirrhosis. Life. 2021;11:399. https://doi.org/10.3390/life11050399.
Hari A. Muscular abnormalities in liver cirrhosis. World J Gastroenterol. 2021;27:4862–78. https://doi.org/10.3748/wjg.v27.i29.4862.
Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, et al. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;76:588–99. https://doi.org/10.1016/j.jhep.2021.11.006.
Saeki C, Kinoshita A, Kanai T, Ueda K, Nakano M, Oikawa T, et al. The Geriatric Nutritional Risk Index predicts sarcopenia in patients with cirrhosis. Sci Rep. 2023;13:3888. https://doi.org/10.1038/s41598-023-31065-1.
Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, et al. Sarcopenia in cirrhosis: prospects for therapy targeted to gut microbiota. World J Gastroenterol. 2023;29:4236–51. https://doi.org/10.3748/wjg.v29.i27.4236.
Nardelli S, Riggio O, Gioia S, Merli M, Spagnoli A, di Martino M, et al. Risk factors for hepatic encephalopathy and mortality in cirrhosis: the role of cognitive impairment, muscle alterations and shunts. Dig Liver Dis. 2022;54:1060–5. https://doi.org/10.1016/j.dld.2021.12.015.
Kim TH, Jung YK, Yim HJ, Baik JW, Yim SY, Lee YS, et al. Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis. Clin Mol Hepatol. 2022;28:876–89. https://doi.org/10.3350/cmh.2022.0231.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. https://doi.org/10.1093/ageing/afy169.
Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461–5. https://doi.org/10.1038/ng.257.
Zillikens MC, Demissie S, Hsu YH, Yerges-Armstrong LM, Chou WC, Stolk L, et al. Large meta-analysis of genome-wide association studies identifies five loci for lean body mass. Nat Commun. 2017;8:80. https://doi.org/10.1038/s41467-017-00031-7.
Klimentidis YC, Raichlen DA, Bea J, Garcia DO, Wineinger NE, Mandarino LJ, et al. Genome-wide association study of habitual physical activity in over 377,000 UK Biobank participants identifies multiple variants including CADM2 and APOE. Int J Obes (Lond). 2018;42:1161–76. https://doi.org/10.1038/s41366-018-0120-3.
Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397–411. https://doi.org/10.1038/nrgastro.2017.38.
Livshits G, Gao F, Malkin I, Needhamsen M, Xia Y, Yuan W, et al. Contribution of heritability and epigenetic factors to skeletal muscle mass variation in United Kingdom twins. J Clin Endocrinol Metab. 2016;101:2450–9. https://doi.org/10.1210/jc.2016-1219.
He L, Khanal P, Morse CI, Williams A, Thomis M. Differentially methylated gene patterns between age-matched sarcopenic and non-sarcopenic women. J Cachexia Sarcopenia Muscle. 2019;10:1295–306. https://doi.org/10.1002/jcsm.12478.
Andreassen OA, Thompson WK, Schork AJ, Ripke S, Mattingsdal M, Kelsoe JR, et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 2013;9:e1003455. https://doi.org/10.1371/journal.pgen.1003455.
Liley J, Wallace C. A pleiotropy-informed Bayesian false discovery rate adapted to a shared control design finds new disease associations from GWAS summary statistics. PLoS Genet. 2015;11:e1004926.
Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7. https://doi.org/10.7554/eLife.34408.
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25. https://doi.org/10.1093/ije/dyv080.
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14. https://doi.org/10.1002/gepi.21965.
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8. https://doi.org/10.1038/s41588-018-0099-7.
Fan YH, Song YQ. IPGWAS: an integrated pipeline for rational quality control and association analysis of genome-wide genetic studies. Biochem Biophys Res Commun. 2012;422:363–8. https://doi.org/10.1016/j.bbrc.2012.04.117.
Hayes B. Overview of statistical methods for genome-wide association studies (GWAS). Methods Mol Biol. 2013;1019:149–69. https://doi.org/10.1007/978-1-62703-447-0_6.
Zhou X-Y, Liu R-K, Zeng C-P. Exploring the novel SNPs in neuroticism and birth weight based on GWAS datasets. BMC Med Genom. 2023;16:167.
Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:D930–4.
Lemoine GG, Scott-Boyer M-P, Ambroise B, Périn O, Droit A. GWENA: gene co-expression networks analysis and extended modules characterization in a single Bioconductor package. BMC Bioinform. 2021;22:267.
Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16:385–95.
Breiman L. Random forests. Mach Learn. 2001;45:5–32.
Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn. 2002;46:389–422.
Baldarelli RM, Smith CL, Ringwald M, Richardson JE, Bult CJ. Mouse genome informatics: an integrated knowledgebase system for the laboratory mouse. Genetics 2024;227. https://doi.org/10.1093/genetics/iyae031.
Guo S, Wu J, Zhou W, Liu X, Liu Y, Zhang J, et al. Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods. Medicine. 2021;100:e25553.
Consortium GO. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43:D1049–56.
Aoki-Kinoshita KF, Kanehisa M. Gene annotation and pathway mapping in KEGG. In: Comparative genomics 2007. Totowa, NJ: Humana Press, pp. 71-91.
Colwill K, Gräslund S. A roadmap to generate renewable protein binders to the human proteome. Nat Methods. 2011;8:551–8. https://doi.org/10.1038/nmeth.1607.
Cannon M, Stevenson J, Stahl K, Basu R, Coffman A, Kiwala S, et al. DGIdb 5.0: rebuilding the drug–gene interaction database for precision medicine and drug discovery platforms. Nucleic Acids Res. 2024;52:D1227–35.
DeLuca DS, Poluzioroviene E, Taminskiene V, Wrenger S, Utkus A, Valiulis A, et al. SERPINA1 gene polymorphisms in a population-based ALSPAC cohort. Pediatr Pulmonol. 2019;54:1474–8. https://doi.org/10.1002/ppul.24422.
Li X, Ortega VE, Ampleford EJ, Graham Barr R, Christenson SA, Cooper CB, et al. Genome-wide association study of lung function and clinical implication in heavy smokers. BMC Med Genet. 2018;19:134. https://doi.org/10.1186/s12881-018-0656-z.
Mihalache F, Höblinger A, Grünhage F, Krawczyk M, Gärtner BC, Acalovschi M, et al. Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma. Aliment Pharm Ther. 2011;33:389–94. https://doi.org/10.1111/j.1365-2036.2010.04534.x.
Greene CM, Marciniak SJ, Teckman J, Ferrarotti I, Brantly ML, Lomas DA, et al. α1-Antitrypsin deficiency. Nat Rev Dis Prim. 2016;2:16051. https://doi.org/10.1038/nrdp.2016.51.
Grayeski PJ, Weidmann CA, Kumar J, Lackey L, Mustoe AM, Busan S, et al. Global 5’-UTR RNA structure regulates translation of a SERPINA1 mRNA. Nucleic Acids Res. 2022;50:9689–704. https://doi.org/10.1093/nar/gkac739.
Nischalke HD, Lutz P, Krämer B, Söhne J, Müller T, Rosendahl J, et al. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease. J Hepatol. 2014;61:1073–9. https://doi.org/10.1016/j.jhep.2014.06.006.
Lin YC, Chang PF, Chang MH, Ni YH. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. Am J Clin Nutr. 2014;99:869–74. https://doi.org/10.3945/ajcn.113.079749.
Cai W, Weng DH, Yan P, Lin YT, Dong ZH, Mailamuguli, et al. Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis. Lipids Health Dis. 2019;18:14 https://doi.org/10.1186/s12944-018-0877-3.
Gou Y, Wang L, Zhao J, Xu X, Xu H, Xie F, et al. PNPLA3-I148M variant promotes the progression of liver fibrosis by inducing mitochondrial dysfunction. Int J Mol Sci. 2023;24. https://doi.org/10.3390/ijms24119681.
Cherubini A, Casirati E, Tomasi M, Valenti L. PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date. Expert Opin Ther Targets. 2021;25:1033–43. https://doi.org/10.1080/14728222.2021.2018418.
Kramer HF, Goodyear LJ. Exercise, MAPK, and NF-kappaB signaling in skeletal muscle. J Appl Physiol (1985). 2007;103:388–95. https://doi.org/10.1152/japplphysiol.00085.2007.
Chen Y, Guan M, Yu F, Yang Z, Yi W, Huang X, et al. Protein tyrosine phosphatase receptor type R (PTPRR) reduces AChR clustering by dephosphorylating MuSK. Dis Markers. 2022;2022:5160624. https://doi.org/10.1155/2022/5160624.
Zhang P, Reue K. Lipin proteins and glycerolipid metabolism: roles at the ER membrane and beyond. Biochim Biophys Acta Biomembr. 2017;1859:1583–95. https://doi.org/10.1016/j.bbamem.2017.04.007.
Scott SA, Mathews TP, Ivanova PT, Lindsley CW, Brown HA. Chemical modulation of glycerolipid signaling and metabolic pathways. Biochim Biophys Acta. 2014;1841:1060–84. https://doi.org/10.1016/j.bbalip.2014.01.009.
Zhang Y, Chen X, Cao Y, Yang Z. C8B in complement and coagulation cascades signaling pathway is a predictor for survival in HBV-related hepatocellular carcinoma patients. Cancer Manag Res. 2021;13:3503–15. https://doi.org/10.2147/cmar.S302917.
Bao Y, Wang L, Shi L, Yun F, Liu X, Chen Y, et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer. Cell Mol Biol Lett. 2019;24:38. https://doi.org/10.1186/s11658-019-0162-0.
Rosso F, Giordano A, Barbarisi M, Barbarisi A. From cell-ECM interactions to tissue engineering. J Cell Physiol. 2004;199:174–80. https://doi.org/10.1002/jcp.10471.
Jia F, Ruan L, Du C, Liu Y, Cai X, Dou R, et al. The nanoformula of zoledronic acid and calcium carbonate targets osteoclasts and reverses osteoporosis. Biomaterials. 2023;296:122059. https://doi.org/10.1016/j.biomaterials.2023.122059.
Jia J, He R, Yao Z, Su J, Deng S, Chen K, et al. Daidzein alleviates osteoporosis by promoting osteogenesis and angiogenesis coupling. PeerJ. 2023;11:e16121. https://doi.org/10.7717/peerj.16121.
Papadopoulou SK, Papadimitriou K, Voulgaridou G, Georgaki E, Tsotidou E, Zantidou O, et al. Exercise and nutrition impact on osteoporosis and sarcopenia—the incidence of osteosarcopenia: a narrative review. Nutrients. 2021;13. https://doi.org/10.3390/nu13124499.
Greco EA, Pietschmann P, Migliaccio S. Osteoporosis and sarcopenia increase frailty syndrome in the elderly. Front Endocrinol. 2019;10:255. https://doi.org/10.3389/fendo.2019.00255.